Figure 5
Figure 5. The CD4 molecule contributes to the greater cytotoxic potential of CD4dimCD8bright T cells compared with CD4−CD8+ T cells. (A-H) Cumulative data (A,F) and representative dot plots (B-E,G-J) of CD107ab staining by CD4−CD8+ and CD4dimCD8bright T cells from HIV+ LTNP (A-E) and CMV+ (F-J) donors, cocultured with T1 target cells with no blocker (A-B,F-G), after blocking targets with MHC-II blocking antibody(A,C,F,H), or CD4 neutralizing antibody (A,D,F,I) or cocultured with T2 targets (A,E,F,J). (A,F) Data represent mean + SD percentage of 107ab expression from at least 3 donors. P values between groups are indicated within the figure and based on 2-tailed unpaired t test analysis.

The CD4 molecule contributes to the greater cytotoxic potential of CD4dimCD8bright T cells compared with CD4CD8+ T cells. (A-H) Cumulative data (A,F) and representative dot plots (B-E,G-J) of CD107ab staining by CD4CD8+ and CD4dimCD8bright T cells from HIV+ LTNP (A-E) and CMV+ (F-J) donors, cocultured with T1 target cells with no blocker (A-B,F-G), after blocking targets with MHC-II blocking antibody(A,C,F,H), or CD4 neutralizing antibody (A,D,F,I) or cocultured with T2 targets (A,E,F,J). (A,F) Data represent mean + SD percentage of 107ab expression from at least 3 donors. P values between groups are indicated within the figure and based on 2-tailed unpaired t test analysis.

Close Modal

or Create an Account

Close Modal
Close Modal